Kmp in dosage-dependent manner prevents the pancreatic cancerous cells growth in PANC-1, MIA PaCa-2, and SNU213-pancreatic cancer cell line by causing apoptosis and efficiently preventing ERK-1/2, EGFR-related AKT and Src signalling pathways and migration of cells. Here, SRC is linked to pancreatic neoplasm.